Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Expert Opinion on Pharmacotherapy|June 22, 2021
Strategies for the diagnosis and management of meningitis in HIV-infected adults in resource limited settingsMarise Bremer, Yakub E Kadernani, Sean Wasserman, et al.
Wellcome Open Research|February 7, 2022
Host Directed Therapies for Tuberculous MeningitisAngharad G Davis, Joseph Donovan, Marise Bremer, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2021
Plasma Pharmacokinetics of High-Dose Oral versus Intravenous Rifampicin in Patients with Tuberculous Meningitis: a Randomized Controlled TrialSean Wasserman, Angharad Davis, Cari Stek, et al.
Trials|March 25, 2026
Fluconazole plus flucytosine versus fluconazole alone for adults with HIV-associated cryptococcal antigenaemia identified through screening: a multi-centre phase III randomised-controlled trialKyla Murphy, Jeremy S Nel, Mahomed-Yunus Moosa, et al.
Scientific Reports|February 16, 2022
Convalescent plasma in the treatment of moderate to severe COVID-19 pneumonia: a randomized controlled trial (PROTECT-Patient Trial)Karin van den Berg, Tanya Nadia Glatt, Marion Vermeulen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 9, 2022
A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus-Associated Tuberculous Meningitis: The LASER-TBM TrialAngharad G Davis, Sean Wasserman, Cari Stek, et al.
Wellcome Open Research|July 21, 2021
Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis [LASER-TBM]Angharad G Davis, Sean Wasserman, Mpumi Maxebengula, et al.
Pageof 1